FDA NDC Directory · JSON-LD · Markdown

Vyalev

NDC 0074-0501 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namefoscarbidopa/foslevodopa
Labeler / ManufacturerAbbVie Inc.
Marketing categoryNew Drug Application (innovator) · App NDA216962
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsFOSCARBIDOPA (12 mg/mL)
FOSLEVODOPA (240 mg/mL)
Marketing started20220412
Package count1

External sources

Source: openFDA. Public-domain (CC0).